Screener
Vertex Pharmaceuticals VRTX Other CF product revenues — Product revenues, net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000875320-26-000173
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| (in millions) | ||
| TRIKAFTA/KAFTRIO | $2,354.7 | $2,535.5 |
| ALYFTREK | 424.4 | 53.9 |
| Other CF product revenues (1) | 135.9 | 155.3 |
| Total CF product revenues, net | 2,915.0 | 2,744.7 |
| CASGEVY | 42.9 | 14.2 |
| JOURNAVX | 29.0 | 1.3 |
| Total product revenues, net | $2,986.9 | $2,760.2 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vertex Pharmaceuticals's other CF product revenues — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported other CF product revenues — product revenues, net of $135.9M in Q1 2026.
- How has Vertex Pharmaceuticals's other CF product revenues — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's other CF product revenues — product revenues, net decreased by 12.5% year-over-year, from $155.3M to $135.9M.
- What is the long-term trend for Vertex Pharmaceuticals's other CF product revenues — product revenues, net?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's other CF product revenues — product revenues, net has grown at a -19.6% compound annual growth rate (CAGR), from $1.24B to $804.6M.
- What does other CF product revenues — product revenues, net mean?
- This metric represents the net revenue generated from secondary or non-core pharmaceutical product lines outside of the company's primary therapeutic franchises. It captures the financial contribution of smaller, emerging, or legacy assets that are not categorized within the firm's main revenue-driving segments. Monitoring this figure helps investors assess the diversification of the product portfolio and the commercial success of secondary pipeline assets.
Ask your AI about Vertex Pharmaceuticals's other cf product revenues — product revenues, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude